<DOC>
	<DOCNO>NCT00855166</DOCNO>
	<brief_summary>This study carry see dapagliflozin addition metformin decrease body weight , compare metformin alone .</brief_summary>
	<brief_title>Evaluation Effect Dapagliflozin Combination With Metformin Body Weight Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Type 2 diabetes Ongoing treatment metformin stable dose ≥1500 mg/day least 12 week prior enrolment Inadequate glycemic control , define HbA1c ≥6.5 % ≤8.5 % ≥30 year males ≥55 year females Type 1 Diabetes Body weight change &gt; 5 % within 3 month prior enrolment Renal liver impairment</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Dapagliflozin</keyword>
	<keyword>Metformin</keyword>
	<keyword>Type 2 diabetes</keyword>
	<keyword>body weight</keyword>
</DOC>